Banco Santander’s West Pharmaceutical WST Stock Holding History

Banco Santander’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-7,537	Closed	-$2.65M	–	466
2023 Q4	$2.65M	Hold	7,537	–	–	0.03%	215
2023 Q3	$2.83M	Buy	7,537 +1,263	+20%	+$488K	0.04%	212
2023 Q2	$2.4M	Hold	6,274	–	–	0.03%	211
2023 Q1	$2.17M	Hold	6,274	–	–	0.03%	170
2022 Q4	$1.48M	Hold	6,274	–	–	0.02%	203
2022 Q3	$1.54M	Hold	6,274	–	–	0.02%	209
2022 Q2	$1.9M	Buy	6,274 +173	+3%	+$56.3K	0.03%	218
2022 Q1	$2.51M	Hold	6,101	–	–	0.03%	217
2021 Q4	$2.86M	Buy	6,101 +586	+11%	+$252K	0.02%	215
2021 Q3	$2.34M	Sell	5,515 -363	-6%	-$153K	0.01%	225
2021 Q2	$2.11M	Sell	5,878 -1,298	-18%	-$429K	0.01%	227
2021 Q1	$2.02M	Sell	7,176 -774	-10%	-$222K	0.01%	212
2020 Q4	$2.25M	Buy	7,950 +5,080	+177%	+$1.43M	0.02%	206
2020 Q3	$789K	Buy	2,870 +994	+53%	+$263K	0.01%	257
2020 Q2	$426K	Buy	+1,876	New	+$369K	0.01%	287

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Banco Santander's WST Position: Q1 2024 in Review

Banco Santander sold out of West Pharmaceutical (WST) in Q1 2024, closing a stake of 7,537 shares — an estimated $2.65M sold.

Banco Santander first reported a position in WST in Q2 2020 and held it in 15 quarters. The position peaked at $2.86M in Q4 2021. 778 funds tracked by Wall St. Rank hold WST as of Q1 2024.

Banco Santander reported no remaining West Pharmaceutical position as of Q1 2024 after selling out during the quarter.
Banco Santander sold 7,537 West Pharmaceutical shares in Q1 2024, an estimated $2.65M.
Banco Santander first reported a position in West Pharmaceutical in Q2 2020 and held it in 15 quarters.
Banco Santander's West Pharmaceutical position peaked at $2.86M in Q4 2021.
778 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2024.

Based on Banco Santander's 13F filing for Q1 2024, filed 10 May 2024.